[HTML][HTML] Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis …
Recently, scientists developed a powerful strategy called “one drug-multiple targets” to
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with …
AS Hassan, NM Morsy, WM Aboulthana… - RSC …, 2023 - ui.adsabs.harvard.edu
Recently, scientists developed a powerful strategy called" one drug-multiple targets" to
discover vital and unique therapies to fight the most challenging diseases. Recently …
discover vital and unique therapies to fight the most challenging diseases. Recently …
Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with …
AS Hassan, NM Morsy, WM Aboulthana… - RSC …, 2023 - pubmed.ncbi.nlm.nih.gov
Recently, scientists developed a powerful strategy called" one drug-multiple targets" to
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
[HTML][HTML] Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis …
AS Hassan, NM Morsy, WM Aboulthana, A Ragab - RSC Advances, 2023 - ncbi.nlm.nih.gov
Recently, scientists developed a powerful strategy called “one drug-multiple targets” to
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
[PDF][PDF] Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis …
AS Hassan, NM Morsy, WM Aboulthanab, A Ragab - 2023 - researchgate.net
Recently, scientists developed a powerful strategy called “one drug-multiple targets” to
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with …
AS Hassan, NM Morsy, WM Aboulthana… - RSC …, 2023 - pure.johnshopkins.edu
Recently, scientists developed a powerful strategy called “one drug-multiple targets” to
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with …
AS Hassan, NM Morsy, WM Aboulthana… - RSC …, 2023 - jhu.pure.elsevier.com
Recently, scientists developed a powerful strategy called “one drug-multiple targets” to
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with …
AS Hassan, NM Morsy, WM Aboulthana, A Ragab - RSC Advances, 2023 - europepmc.org
Recently, scientists developed a powerful strategy called “one drug-multiple targets” to
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
[PDF][PDF] Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis …
AS Hassan, NM Morsy, WM Aboulthanab, A Ragab - 2023 - researchgate.net
Recently, scientists developed a powerful strategy called “one drug-multiple targets” to
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …
discover vital and unique therapies to fight the most challenging diseases. Novel derivatives …